Increased circulating 92 kDa matrix metalloproteinase (MMP-9) activity in exacerbations of asthma

Thorax

Volumn 58, Issue 9, 2003, Pages 757-760

  Oshita, Y ^a   Koga, T ^a   Kamimura, T ^a   Matsuo, K ^a   Rikimaru, T ^a   Aizawa, H ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; CONVALESCENCE; DISEASE EXACERBATION; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; ZYMOGRAPHY;

ADULT; ASTHMA; CALORIMETRY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0042330176     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.9.757     Document Type: Article

References (26)

1. Bousquet J, Jeffery PK, Busse WW, et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45.
2. Chetta A, Foresi A, Del Donna M, et al. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111:852-7.
3. Louis R, Lau LC, Bran AO, et al. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16.
4. Dunnill MS, Massarella GR, Anderson JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969;24:176-9.
5. Roche WR, Beasley R, Williams JH, et al. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520-4.
6. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:S28-38.
7. Busse W, Elias J, Sheppard D, et al. Airway remodeling and repair. Am J Respir Crit Care Med 1999;160:1035-42.
8. Tanaka H, Masuda T, Takuoka S, et al. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm Res 2001;50:616-24.
9. Keck T, Balcom JHt, Fernandez-del Castillo C, et al. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 2002;122:188-201.
10. Okada S, Kita H, George TJ, et al. Migration of eosinophlis through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997;17:519-28.
11. GINA Pocket guide for asthma management and prevention. NIH Publication 96-3659B. National Institutes of Health, National Heart, Lung and Blood Institute, 1998.
12. Verheijen JH, Nieuwenbroek NM, Beekman B, et al. Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase. Biochem J 1997;323:603-9.
13. Hrabec E, Strek M, Nowak D, et al. Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. Respir Med 2001;95:1-4.
14. Quesada AR, Barbacid MM, Mira E, et al. Evaluation of fluorometric and zymographic methods as activity assays for stromelysins and gelatinases. Clin Exp Metastasis 1997;15:26-32.
15. Bossé M, Chakir J, Rouabhia M, et al. Serum matrix metalloproteinase-9:tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999;159:596-602.
16. Beeh KM, Beier J, Kornmann O, et al. Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant 2001;20:1144-51.
17. Kumagai K, Ohno I, Okada S, et al. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 1999;162:4212-9.
18. Corbel M, Theret N, Caulet-Maugendre S, et al. Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity. Inflamm Res 2001;50:129-35.
19. Hoshino M, Nakamura Y, Sim J, et al. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998;102:783-8.
20. Lemjabbar H, Gosset P, Lamblin C, et al. Contribution of 92 kDa gelatinase/lype IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med 1999;159:1298-307.
21. Cataldo DD, Bettiol J, Noel A, et al. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002;122:1553-9.
22. Leppert D, Waubant E, Galardy R, et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-89.
23. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. Chest 1999;116:285-95.
24. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-9.
25. Grünberg K, Sharon RF, Sont JK, et al. Rhinovirus-induced airway inflammation in asthma. Effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 2001;164:1816-22.
26. Mattos W, Lim S, Russell R, et al. Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids. Chest 2002;122:1543-52.